Sittner & Nelson’s NanoViricides NNVC Stock Holding History

Sittner & Nelson’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$913	–	637
2026 Q1	$913	Hold	1,000	–	–	﹤0.01%	538
2025 Q4	$880	Buy	+1,000	New	+$1.4K	﹤0.01%	507

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Sittner & Nelson's NNVC Position: Q2 2026 in Review

Sittner & Nelson sold out of NanoViricides (NNVC) in Q2 2026, closing a stake of 1,000 shares — an estimated $913 sold.

Sittner & Nelson first reported a position in NNVC in Q4 2025 and held it in 2 quarters. The position peaked at $913 in Q1 2026. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Sittner & Nelson reported no remaining NanoViricides position as of Q2 2026 after selling out during the quarter.
Sittner & Nelson sold 1,000 NanoViricides shares in Q2 2026, an estimated $913.
Sittner & Nelson first reported a position in NanoViricides in Q4 2025 and held it in 2 quarters.
Sittner & Nelson's NanoViricides position peaked at $913 in Q1 2026.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.